Skip to main content
. 2009 Jan;67(1):125–129. doi: 10.1111/j.1365-2125.2008.03333.x

Table 1.

Exclusion criteria from this study

Number Criteria
1 Patients who had received any diclofenac sodium or mefenamic acid preparation within 2 weeks before the start of the study
2 Patients who had received an injection of a steroid, sodium hyaluronate, etc., into the affected joint within a week before the start of the study
3 Patients with wounds or diseases in the skin around the knee
4 Patients with a history of hypersensitivity to a certain drug
5 Patients suffering from a peptic ulcer
6 Patients with severe underlying internal diseases (heart disease, renal disease, coronary artery disease, haematological disease, etc.) or history of such diseases
7 Patients with a history of hypersensitivity to a certain nonsteroidal anti-inflammatory drug (especially diclofenac sodium)
8 Pregnant or possibly pregnant women
9 Nursing women
10 Other patients judged, for any reason, to be unsuitable for the study by the attending physician